Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Amino diacids containing peptide modifiers

a technology of amino diacids and modifiers, which is applied in the field of amino diacids containing peptide modifiers, can solve the problems of increasing the complexity of the modifiers, the clearance of native peptides or analogues thereof,

Inactive Publication Date: 2016-07-21
CHEM & BIOPHARML LAB OF PATRAS
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention relates to a compound of Formula 1 and its salt, which can be used to make a resin conjugate. The compound has various terminal groups that can be attached to a resin, allowing for selective cleavage in the presence of certain groups. The compound can also have different side groups that can be used to modify its properties. The resin conjugate can be used in various applications, such as in the field of drug discovery. The technical effects of the invention include improved efficiency in drug discovery and the creation of new compounds with specific properties.

Problems solved by technology

Native peptides or analogues thereof generally have a high clearance, which is problematic if a prolonged period of biological activity is desired.
As the complexity of the modifiers increase, so does their synthesis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amino diacids containing peptide modifiers
  • Amino diacids containing peptide modifiers
  • Amino diacids containing peptide modifiers

Examples

Experimental program
Comparison scheme
Effect test

example 1

General Method for the Synthesis of Side Chain Modified Diamino Acid Derivatives with the General Formula 1 in Aqueous Solution by the Acylation Fmoc-Lys-OH

[0271]To 18.4 g Fmoc-Lys-OH 200 ml Dioxan / 10%-NaHCO3(1:1) were added. The obtained mixture was then cooled to 0-5° C. and then equimolar amounts of Z—(Y)b—OH in 100 ml dioxan were added and the mixture was stirred for 2 h at 0-5° C. and 2 h at RT. The mixture was then diluted with 0.1 N—HCl and extracted with EtAc. The organic layer was then washed with 5%-NaHCO3, H2O, 0.1 N—HCl, H2O and brine, dryed over anhydrous Na2SO4 and concentrated in the RE. The obtained oily product precipitated by the addition of DEE or petroleum ether or water. The obtained solid was filtered and washed with DEE or PE or water and dried in vacuum. Yield 60-95%.

example 2

General Method for the Synthesis of Side Chain Modified Diamino Acid Derivatives with the General Formula 1 in Organic Solution by the Acylation of Fmoc-Lys-OH

[0272]To a suspension of 18.4 g Fmoc-Lys-OH in 200 ml DCM 5.4 ml Me3SiCl were added at 0° C. and stirred for 3 h. Then 12.9 ml DIPEA were added and stirred for additional 30 min. Then a solution of equimolar amounts of Z—(Y)b—OH, EDAC.HCl and HOSu in 100 ml anhydrous DMF were added and the mixture was stirred for 4 h at 10-15° C. The mixture was then diluted with 1 N—HCl and extracted with EtAc. The organic layer was then washed with 5%-NaHCO3, H2O, 0.1N—HCl, H2O and brine, dried over anhydrous Na2SO4 and concentrated in the RE. The obtained oily products precipitated by the addition of DEE or petroleum ether or water. The obtained solids were filtered washed with DEE and hexane and dried in vacuum. Yield: 65-95%.

example 3

Synthesis of N-Trityl-glutamic acid α-tert-butyl ester (Trt-Glu-OtBu). Formula Nr. 2′-1

[0273]

[0274]40.6 g H-Glu-(OtBu) were suspended in 400 ml DCM and cooled to 0° C. Then 21.7 g chlorotrimethylsilane were added dropwise and the mixture was stirred until a clear solution was obtained. Then 52 g DIPEA were added followed by 56 g Trt-Cl and the mixture was stirred for additional 2 h at 0° C. and warmed up to RT and stirred farther for additional 2 h. Then 20 ml MeOH were added and the mixture was concentrated in vacuum and then 500 ml DEE were added and the product was extracted and purified by acidic-basic extraction. The organic solution was concentrated in vacuum and the Trt-Glu-OtBu was obtained as syrup. Yield: 86.0 g (76.7%). The obtained syrup can be converted to solid diethylammonium salt by dissolving it in 350 ml DEE and adding to the solution 15 g DEA.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The present invention relates to peptide modifier compounds of Formula (1), or a salt thereof, wherein: a is an integer from 1 to 10, more preferably from 1 to 3; b is an integer from 0 to 7; Z is a terminal group and Y is a bivalent group. Further aspects of the invention relate to intermediates in the preparation of compounds of Formula (1), and the use of compounds of Formula 1 in the synthesis of peptide derivatives.

Description

[0001]The present invention relates to peptide modifiers with applications in the synthesis of modified peptide derivatives.BACKGROUND OF THE INVENTION[0002]Peptides are widely used as pharmaceuticals and their application is expected to increase in future. They can be produced by recombinant DNA technology or by conventional chemical synthesis.[0003]Native peptides or analogues thereof generally have a high clearance, which is problematic if a prolonged period of biological activity is desired.[0004]Pharmaceutical peptides which have a high clearance include, for example, ACTH, angiotensin, calcitonin, insulin, glucagon-like peptide-1, glucagon-like peptide-2, insulin like growth factor-1, insulin-like growth factor-2, growth hormone releasing factor, thrombopoietin, erythropoietin, hypothalamic releasing factors, prolactin, PTH and related peptides, endorphins, enkephalins and other opioids, vasopressin, oxytocin, fuzeon, and the like. In many cases it is possible to modify the re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K1/107C07C269/04C07C269/06C07C323/60C07K14/62C08F112/14C07K14/605C07K14/505C07K14/575C07K14/635C07K14/47C07K14/00C07C271/02A61K47/48
CPCC07K1/1075C07C271/02C07C269/04C07C269/06C07C323/60C07K14/62A61K47/48038C07K14/605C07K14/505C07K14/575C07K14/635C07K14/473C07K14/57509C07K14/4703C07K14/00C08F112/14C07C2103/18A61K38/00C07C233/47C07C235/12C07C237/22C07C271/16C07C271/22C07C323/52C07K1/04C07K1/107C07K14/695C07K1/1077C07C2603/18A61K47/542A61K47/62A61P43/00Y02P20/55
Inventor BARLOS, KLEOMENISGATOS, DIMITRIOSBARLOS, KOSTAS K.VASILEIOU, ZOI
Owner CHEM & BIOPHARML LAB OF PATRAS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com